Concepedia

165MO Trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients (pts) with active brain metastases: Primary outcome analysis from the TUXEDO-1 trial

Rupert Bartsch, Anna S. Berghoff, Julia Furtner, Maximilian Marhold, Elisabeth Bergen, S. Roider-Schur, Angelika M. Starzer, Heidrun Forstner, Beate Rottenmanner, Karin Dieckmann,

Annals of Oncology · 2022 · 17 citations · 0 references

Concepts

MedicineOncologyBreast OncologyChemotherapyImmunotherapyBrain MetastasesBrain MetastasisCancer ImmunotherapyHer2-positive Breast CancerImmunotherapy For Breast CancerMetastatic Breast CancerBrain Metastasis Systemic TherapyBrain Metastasis TrialsHer2-positive Breast Cancer ImmunotherapyHer2-positive Breast Cancer TherapyHer2-positive Metastatic DiseaseMetastatic Breast Cancer TreatmentMetastatic Her2-positive Breast CancerPrimary Outcome Analysis